USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: HEMOGENIX, LLC
City: GREENWOOD
State: SC
Zip+4: 29646
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (864) 388-1818

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $120,000.00 2
SBIR Phase II $926,630.00 1

Award List:

AN IN VITRO HIGH THROUGHPUT STEM CELL HEMOTOXICITY ASSAY

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ivan N. Rich
Award Amount: $120,000.00
Abstract:
Present hemotoxicity testing during drug development has a low predictability level. In contrast, the in vitro hematopoietic stem and progenitor cell colony-forming assays (CFA) provide validated and highly predictive procedures which can be extrapolated to other proliferating cell systems and are… More

An In Vitro Throughput Stem Cell Hemotoxicity Assay

Award Year / Program / Phase: 2003 / SBIR / Phase I
Agency: HHS
Principal Investigator: Ivan N. Rich
Award Amount: $0.00
Abstract:
DESCRIPTION (provided by applicant): Conventional hemotoxicity testing, performed primarily during the preclinical phase of drug development, is based on parameters obtained from mature cells in peripheral blood or organ morphology and, as such, has little predictive value. The in vitro… More

An In Vitro Throughput Stem Cell Hemotoxicity Assay

Award Year / Program / Phase: 2003 / SBIR / Phase II
Agency: HHS
Principal Investigator: Ivan N. Rich
Award Amount: $926,630.00
Abstract:
DESCRIPTION (provided by applicant): Conventional hemotoxicity testing, performed primarily during the preclinical phase of drug development, is based on parameters obtained from mature cells in peripheral blood or organ morphology and, as such, has little predictive value. The in vitro… More